Purple Biotech (PPBT) Times Interest Earned (2014 - 2026)

Purple Biotech (PPBT) has 12 years of Times Interest Earned data on file, last reported at $72.61 in Q1 2026.

• Times Interest Earned for Q1 2026 came in at $72.61, up 80.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $123.04 (up 669.31% YoY), and the FY2025 annual result was $27.96, up 22.72% from the prior year.
• Times Interest Earned eased to $72.61 in Q1 2026 per PPBT's latest filing, from $109.56 in the prior quarter.
• Over five years, Times Interest Earned peaked at $366.72 in Q4 2022 and troughed at -$61.8 in Q2 2025.
• A 5-year average of $127.81 and a median of $86.81 in 2023 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2022 and 2024: Times Interest Earned surged 9067.33% in 2022, then tumbled 590.82% in 2024.
• A 5-year view of Times Interest Earned shows it stood at $366.72 in 2022, then tumbled by 99.18% to $3.0 in 2023, then plunged by 590.82% to -$14.72 in 2024, then jumped by 844.06% to $109.56 in 2025, then tumbled by 33.72% to $72.61 in 2026.
• Business Quant data shows PPBT's Times Interest Earned at $72.61 in Q1 2026, $109.56 in Q4 2025, and $273.4 in Q3 2025.